<i>MUC5B</i> Promoter Polymorphism and Development of Acute Respiratory Distress Syndrome
Angela J. Rogers, Lorraine B. Ware(Vanderbilt University Medical Center), Nuala J. Meyer(Translational Therapeutics (United States)), Timothy S. Blackwell(University of Michigan), Rebecca M. Baron(Brigham and Women's Hospital), Addison K. May(Vanderbilt University Medical Center), David A. Schwartz(Perinatal Institute), William E. Lawson(VA Tennessee Valley Healthcare System), Joseph F. Solus(Vanderbilt University), David R. Janz(Louisiana State University), Gary M. Hunninghake(Hubei University of Science and Technology)
Cited by 11
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
|New England Journal of Medicine|2007|1.4k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Toll-like Receptor 4 Polymorphisms and Atherogenesis
|New England Journal of Medicine|2002|1k